Cancer Treatment Reviews
Volume 31, Issue 4 , Pages 247-255 , June 2005

Brain metastasis of unknown primary: A diagnostic and therapeutic dilemma

  • Konstantinos S. Polyzoidis

      Affiliations

    • Department of Neurosurgery, Medical School, University of Ioannina, P.O. Box 1186, Post code 45110, Ioannina, Greece
    • Corresponding Author InformationCorresponding author. Tel.: 0030 26510 97527; fax: 0030 26510 97030
    • ,
  • George Miliaras

      Affiliations

    • Department of Neurosurgery, Medical School, University of Ioannina, P.O. Box 1186, Post code 45110, Ioannina, Greece
    • Tel.: 0030 26510 97527; fax: 0030 26510 97030.
    • ,
  • Nicholas Pavlidis

      Affiliations

    • Department of Medical Oncology, Medical School, University of Ioannina, Post code 45110, Ioannina, Greece
    • Tel./fax: 0030 26510 99394.

References 

  1. Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases: histology, multiplicity, surgery and survival. Cancer. 1996;78:1781–1788
  2. Bartelt S, Lutterbach J. Brain metastases in patients with cancer of unknown primary. J Neurooncol. 2003;64:249–253
  3. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39:1990–2005
  4. Holmes FF, Fouts TL. Metastatic cancer of unknown primary site. Cancer. 1970;26:816–820
  5. Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN. Analysis of diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol. 1995;13:2094–2103
  6. Frost P, Raber MN, Abbruzzese JL. Unknown primary tumors as a unique clinical and biologic entity: a hypothesis. Cancer Bull. 1989;41:139–141
  7. Eapen L, Vachet M, Catton G, et al. Brain metastases with an unknown primary: a clinical perspective. J Neurooncol. 1988;6:31–35
  8. Maesawa S, Kondziolka D, Thompson T, Flickinger J, Lunsford L. Brain metastases in patients with no known primary tumor. The role of stereotactic radiosurgery. Cancer. 2000;89:1095–1101
  9. Sawaya R, Bindal RK, Lang FF, Abi-Said D. Metastatic brain tumors. In:  Kaye AH,  Laws ER editor. Brain tumors. An encyclopedic approach. London: Churchill Livingstone; 2001;p. 999–1026
  10. Cairncross JG, Postner JB. The management of brain metastases. In:  Walker MD editors. Oncology of the nervous system. Boston: Nijhoff; 1983;p. 341–377
  11. Kehrli P. Epidemiology of brain metastases. Neurochirurgie. 1999;45:357–363[in French]
  12. Mintz AH, Kestle J, Rathbone MP, et al. A randomized trail to asses the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer. 1996;78:1470–1476
  13. Sheehan J, Niranjan A, Flickinger J, Kondziolka K, Lunsford D. The expanding role of neurosurgeons in the management of brain metastases. Surg Neurol. 2004;62:32–41
  14. Vecht CJ. Clinical management of brain metastasis. J Neurol. 1998;245:127–131
  15. Subramanian A, Harris A, Piggott K, Shieff C, Bradford R. Metastasis to and from the central nervous system – the “relatively protected site. Lancet. 2002;3:498–506
  16. Bender AL, Posner JB. Current treatment of brain metastases. In:  Maciunas RJ editors. Advanced techniques in central nervous system metastases. Park Ridge: Neurosurgical Topics, AANS; 1998;p. 1–15
  17. Petrovich Z, Yu C, Giannotta SL, O’Day S, Apuzzo MLJ. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg. 2002;97(Suppl. 5):499–506
  18. Paillas JE, Pellet W. Brain metastases. In:  Vinken PJ,  Bruyn GW editor. Handbook of clinical neurology: tumours of the brain and skull, Part 3. vol. 18:Amsterdam: North Holland Publishing Co.; 1975;p. 201–232
  19. Posner JB. Management of central nervous system metastases. Semin Oncol. 1977;4:81–91
  20. Weisberg LA. Computerized tomography in intracranial metastases. Arch Neurol. 1979;36:630–634
  21. Salvati M, Cervoni L, Raco A. Single brain metastases from unknown primary malignancies in CT-era. J Neurooncol. 1995;23:75–80
  22. Macchiarini P, Buonaguidi R, Hardin M, Mussi A, Angeletti CA. Results and prognostic factors of surgery in the management of non-small cell lung cancer with solitary brain metastasis. Cancer. 1991;68:300–304
  23. Morita R, Fujimoto A, Hatta N, Takehara K, Takata M. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression. J Invest Dermatol. 1998;111:919–924
  24. Ruan S, Fuller G, Levin V, Bruner JM, Zhang W. Detection of p21WAF1/Cip1 in brain metastases. J Neurooncol. 1998;37:223–228
  25. van de Pol M, van Aalst VC, Wilmink JT, Twijnstra A. Brain metastases from an unknown primary tumour: which diagnostic procedures are indicated. J Neurol Neurosurg Psychiatry. 1996;61:321–323
  26. Le Chevalier T, Smith FP, Caille P, Costans JP, Rouesse JG. Sites of primary malignancies in patients presenting with cerebral metastases. A review of 120 cases. Cancer. 1985;56:880–882
  27. Ruda R, Borgognone M, Benech F, Vasario E, Soffietti R. Brain metastases from unknown primary tumour. A prospective study. J Neurol. 2001;248:394–398
  28. Milovic M, Popov I, Jelic S. Tumor markers in metastatic disease from cancer of unknown primary origin. Med Sci Monit. 2002;8:MT25–MT30
  29. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1980;6:1–9
  30. Vieth RG, Odom GL. Intracranial metastases and their neurosurgical treatment. J Neurosurg. 1965;23:375–383
  31. Winston KR, Walsh JW, Fischer EG. Results of operative treatment of intracranial metastatic tumors. Cancer. 1980;45:2639–2645
  32. Yamada K, Miura M, Miyayama H, et al. Brain metastases from asymptomatic adenocarcinoma of the pancreas. An autopsy case report. Surg Neurol. 2002;58:332–337
  33. Dennis JL, Vass JK, Wit EC, Keith N, Oien KA. Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin. Cancer Res. 2002;62:5999–6005
  34. Greco FA, Hainsworth JD. Cancer of unknown primary site. In:  Devita TV,  Hellman S,  Rosenberg SA editor. Cancer: principles and practice of oncology. 4th ed.. Philadelphia: JB Lippincott Co; 1997;p. 2423–2443
  35. Soffietti R, Ruda R, Mutani R. Management of brain metastases. J Neurol. 2002;249:1357–1369
  36. Mandybur TI. Intracranial haemorrhage caused by metastatic tumours. Neurology. 1977;27:650–655
  37. Li Y, Takayasu M, Takagi T, et al. Intramedullary spinal cord metastasis associated with hemorrhage: a case report. No Shinkei Geka. 2000;28:453–457[in Japanese]
  38. Bhushan C. “Miliary” metastatic tumors in the brain. J Neurosurg. 1997;86:564–566
  39. Bolla L, Palmer RM. Paraneoplastic cerebellar degeneration. Case report and literature review. Arch Intern Med. 1997;157:1258–1262
  40. Pissas A, Perret J, de Rougemont J, et al. The metastatic meningoradiculitis. An exceptional detection of a gastric cancer. Review of the literature about one case (Author Trans.). Sem Hop. 1981;57:1185–1191[in French]
  41. Nguyen LN, Maor MH, Oswald MJ. Brain Metastases as the only manifestation of an undetected primary tumor. Cancer. 1998;83:2181–2184
  42. Srikanth SG, Jayakumar PN, Chandrashekar HS. CT features of intracranial metastases of unknown primaries. Neurol lndia. 2002;50:282–285
  43. DeAngelis LM, Gutin PH, Leibel SA, Posner JB. Intracranial tumors. Diagnosis and treatment. London: Martin Dunitz Ltd; 2002;p. 367–394
  44. Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol. 1988;45:741–744
  45. Pengel J, Crevits L, Wynants P, et al. Optic nerve metastasis simulating optic neuritis. Clin Neurol Neurosurg. 1997;99:46–49
  46. Ruelle A, Palladino M, Andrioli GC. Pituitary metastases as presenting lesions of malignancy. J Neurosurg Sci. 1992;36:51–54
  47. McEvoy AW, Khan N, Kitchen ND. Bitemporal hemianopia caused by metastatic carcinoma in a patient with Wegener’s granulomatosis: an unexpected finding. Br J Neurosurg. 1997;11:579–581
  48. Mak W, Cheung RT, Fan YW, Ho SL. Metastatic adenocarcinoma masquerading as basal pontine tuberculoma. Clin Neurol Neurosurg. 1999;101:111–113
  49. van Seters AP, Bots GT, van Dulken H, Luyendijk W, Vielvoye GJ. Metastasis of an occult gastric carcinoma suggesting growth of prolactinoma during bromocriptine therapy: a case report with a review of the literature. Neurosurg. 1985;16:813–817
  50. Iglesias-Rozas JR, Kroh H, Sauer E, Sarioglu N. Disseminated melanomatosis of the central nervous system and other organs: a case report. Clin Neuropathol. 1989;8:11–15
  51. Voorhies RM, Sundaresan N, Thaler HT. The single supratentorial lesion. An evaluation of preoperative diagnostic tests. J Neurosurg. 1980;53:364–368
  52. Sze G, Johnson C, Kawamura Y, et al. Comparison of single- and triple-dose contrast material in the MR screening of brain metastases. AJNR Am J Neuroradiol. 1998;19:821–828
  53. Lee JH, Na DG, Choi KH, et al. Subcortical low intensity on MR images of meningitis, viral encephalitis, and leptomeningeal metastasis. AJNR Am J Neuroradiol. 2002;23:535–542
  54. Le Chevalier T, Cvitkovic E, Caille P, et al. Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med. 1988;148:2035–2039
  55. Agazzi S, Pampallona S, Pica A, et al. The origin of brain metastases in patients with an undiagnosed primary tumour. Acta Neurochir (Wien). 2004;146:153–157
  56. Karsell PR, Sheedy PF, O’Connell MJ. Computed tomography in search of cancer of unknown origin. JAMA. 1982;248:340–343
  57. McMillan JH, Levine E, Stephens RH. Computed tomography in the evaluation of metastatic adenocarcinoma from an unknown primary site. A retrospective study. Radiology. 1982;143:143–146
  58. Merchut MP. Brain metastases from undiagnosed systemic neoplasms. Arch Intern Med. 1989;149:1076–1080
  59. Kole AC, Nieweg OE, Pruim J, et al. Detection of unknown occult primary tumours using positron emission tomography. Cancer. 1998;82:1160–1166
  60. Sengupta MS, Lee SJ, Hoh CK, Phelps ME, Maddahi J. Utility and cost effectiveness of FDG whole body PET in patients with unknown primary malignancies. J Nucl Med. 1995;36(Suppl.):56P;[abstract, 226]
  61. Gutzeit A, Antoch G, et al. Unknown primary tumors: detection with dual-modality PET/CT – Initial experience. Radiology. 2005;234:227–234
  62. Giordana MJ, Cordera S, Boghi A. Cerebral metastases as first symptom of cancer: a clinico-pathologic study. J Neurooncol. 2000;50:265–273
  63. Bar-Eli M, Abbruzzese JL, Lee-Jackson D, Frost P. p53 gene mutation spectrum in human unknown primary tumors. Anticancer Res. 1993;13(5A):1619–1623
  64. Casciato DA, Tabbarah HJ. Metastases of unknown origin. In:  Haskell CM editors. Cancer treatment. 3rd ed.. Philadelpia: WB Saunders; 1990;p. 798–814
  65. Debevec M. Management of patients with brain metastasis of unknown origin. Neoplasma. 1990;37:601–606
  66. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322:494–500
  67. Hess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL. Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. Clinical Cancer Research. 1999;5:3403–3410
  68. Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54:1886–1893
  69. Kuijlen JM, Teernstra OP, Kessels AG, Herpers MJ, Beuls EA. Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis. Seizure. 1996;5:291–298
  70. Patchell R. The management of brain metastases. Cancer Treat Rev. 2003;29:533–540
  71. Muacevic A, Kreth FW, Horstmann GA, et al. Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg. 1999;91:35–43
  72. Shuto T, Fujino H, Asada H, Inomori S, Nagano H. Gamma knife radiosurgery for metastatic tumours in the brain stem. Acta Neurochir. 2003;145:755–760
  73. Chang EL, Hassenbusch SJ, Shiu AS, et al. The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases. Neurosurgery. 2003;53:272–281
  74. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665–1672
  75. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989;39:789–796
  76. Boogerd V, Dalesio O, Bais EM, van der Sande JJ. Response of brain metastasis from breast cancer to systemic chemotherapy. Cancer. 1992;69:972–980
  77. Perry A, Parisi JE, Kurtin PJ. Metastatic adenocarcinoma to the brain: an immunohistochemical approach. Hum Pathol. 1998;28:938–943
  78. Taddei GL, Moncini D, Raspollini MR, et al. Metastatic brain tumors. Pathologica. 1999;91:13–17
  79. Greco FA, Hainsworth JD. Tumors of unknown origin. CA Cancer J Cl. 1992;42:96–115

PII: S0305-7372(05)00056-3

doi: 10.1016/j.ctrv.2005.03.006

Cancer Treatment Reviews
Volume 31, Issue 4 , Pages 247-255 , June 2005

Article Tools